| Authors: |
Dagnew AF; Gates Medical Research Institute, Cambridge, MA, USA. Electronic address: alemnew.dagnew@gatesmri.org., Schmidt AC; Gates Medical Research Institute, Cambridge, MA, USA., Cinar A; Gates Medical Research Institute, Cambridge, MA, USA., Garcia-Basteiro AL; Centro De Investigação Em Saúde De Manhiça, Manhiça, Mozambique; ISGlobal, Hospital Clínic - Universitat De Barcelona, Barcelona, Spain; Centro De Investigación Biomédica En Red De Enfermedades Infecciosas, Barcelona, Spain., Noble R; Gates Medical Research Institute, Cambridge, MA, USA., Pelzer PT; IAVI, Amsterdam, the Netherlands., Churchyard GJ; Aurum Institute, Parktown, South Africa; School of Public Health, University of the Witwatersrand, Johannesburg, South Africa; Department of Medicine, Vanderbilt University, Nashville, TN, USA., Hatherill M; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Department of Pathology, University of Cape Town, Cape Town, South Africa., White RG; TB Modelling Group, TB Centre and Centre for Mathematical Modelling of Infectious Diseases, Department of Infectious Disease Epidemiology, Faculty of Epidemiology & Population Health, London School of Hygiene and Tropical Medicine, London, UK., Cobelens F; Amsterdam UMC, Location University of Amsterdam, Department of Global Health and Amsterdam Institute for Global Health and Development, Amsterdam, the Netherlands; Amsterdam Public Health, Amsterdam, the Netherlands; Amsterdam Infection & Immunity, Amsterdam, the Netherlands. |
